Approval · Notice of Compliance 5565 · 2004
CARBOLITH: Notice of Compliance 5565
Issued October 12, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5565
- Date
- October 12, 2004
- Company
- Valeant Canada LpLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antimanic agent
Products in this notice
Medicinal ingredients
- LITHIUM CARBONATE 150 MG per CAP
- LITHIUM CARBONATE 300 MG per CAP
- LITHIUM CARBONATE 600 MG per CAP